Safety and Efficacy Study of Cefdinir Oral Suspension, in Pediatric Subjects to Treat Acute Otitis Media

Study Identifier
M01-352
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Results Available

Scientific Result Summary
Available Language(s): English

Study Details

Medical Condition
  • Bacterial Infection
  • Study Drug
  • cefdinir
  • Phase
    CSR.ORG
    Sex
    Female & Male
    Age
    6 Months - 4 Years

    Protocol Summary

    To evaluate the safety and efficacy of cefdinir oral suspension in children between 6 months

    and 4 years of age, with acute otitis media, who are at risk of persistent or recurrent

    otitis media.

    Study Locations

    Location
    Status
    Location
    Scottsdale, Arizona, United States, 85258
    Status
    Not applicable
    Location
    Clovis, California, United States, 93611
    Status
    Not applicable
    Location
    Dinuba, California, United States, 93618
    Status
    Not applicable
    Location
    Folsom, California, United States, 95630
    Status
    Not applicable
    Location
    Denver, Colorado, United States, 80218
    Status
    Not applicable
    Location
    Brooklyn, New York, United States, 11203
    Status
    Not applicable
    Showing {first} - {last} of {total} Results